English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2 Journal article
Duncton M.A.J., Piatnitski Chekler E.L., Katoch-Rouse R., Sherman D., Wong W.C., Smith II L.M., Kawakami J.K., Kiselyov A.S., Milligan D.L., Balagtas C., Hadari Y.R., Wang Y., Patel S.N., Rolster R.L., Tonra J.R., Surguladze D., Mitelman S., Kussie P., Bohlen P., Doody J.F.. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2[J]. Bioorganic and Medicinal Chemistry, 2009, 17(2), 731-740.
Authors:  Duncton M.A.J.;  Piatnitski Chekler E.L.;  Katoch-Rouse R.;  Sherman D.;  Wong W.C.; et al.
Favorite | TC[WOS]:38 TC[Scopus]:38 | Submit date：2019/01/16
Angiogenesis  Arylphthalazine  Inhibitor  Kdr  Kinase  Phthalazine  Vegfr-2  
Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors Journal article
Piatnitski Chekler E.L., Katoch-Rouse R., Kiselyov A.S., Sherman D., Ouyang X., Kim K., Wang Y., Hadari Y.R., Doody J.F.. Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors[J]. Bioorganic and Medicinal Chemistry Letters, 2008, 18(15), 4344-4347.
Authors:  Piatnitski Chekler E.L.;  Katoch-Rouse R.;  Kiselyov A.S.;  Sherman D.;  Ouyang X.; et al.
Favorite | TC[WOS]:11 TC[Scopus]:11 | Submit date：2019/01/16
Angiogenesis  Kinase Inhibitor  Vascular Endothelial Growth Factor